COVID-19 VACCINE DEMAND HIGH IN LATAM, MIDDLE EAST AND ASIA - SAID ASTRAZENECA
FRANKFURT - AstraZeneca said global interest in government purchase agreements for its COVID-19 vaccine was driven by strong demand in Latin America, the Middle East and Asia, even as aggregate global demand this year will fall.
As report to media call after the release of the company's fourth-quarter results, CEO Pascal Soriot said the shot, branded Vaxzevria, is receiving a " fantastic welcome " in those regions.
The drugmaker earlier flagged a likely fall in COVID-19 related product sales in year 2022, as an expected decline in vaccine revenue is to be partially offset by growth in sales of its antibody drug Evusheld.
>>>READ MORE ARTICLE HERE<<<
@ Jackie San